Layton H. Smith, PhD , is Director of Drug Discovery and Pharmacology at the Sanford Burnham Prebys Medical Discovery Institute in Orlando, Florida. In this role he provides overall operational and scientific leadership to the Conrad Prebys Center for Chemical Genomics at the Institute, a 30-person drug discovery enterprise equipped with state-of-the-art ultra-high throughput screening and lead discovery capabilities.
The Burnham Prebys Medical Discovery Institute is part of Lake Nona Medical City - a “650-acre health and life sciences... and a premier location for medical care, research and education,” according to the city of Orlando’s website.
R&D is pleased to welcome Dr. Smith to the 2017 R&D 100 Conference. He will be sharing his experience during a general session on Friday, November 17th.
